Drugs that contain Leuprolide Mesylate

1. List of Camcevi Kit drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10646572 ACCORD Pharmaceutical compositions with enhanced stability
Jan, 2027

(3 years from now)

US9572857 ACCORD Pharmaceutical compositions with enhanced stability
Jan, 2027

(3 years from now)

US9744207 ACCORD Pharmaceutical compositions with enhanced stability
Jan, 2027

(3 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) May 25, 2024

Market Authorisation Date: 25 May, 2021

Treatment: NA

Dosage: EMULSION;SUBCUTANEOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic